The healthcare industry is ripe for disruption
And we are partnering with the disruptors
We’re passionate about using technology to create efficiencies and improve outcomes in the healthcare industry and we’re partnering with teams who share our passion for innovation that provokes a new way of thinking about treatments, devices and cures.
NLVP has nurtured and built great companies with a singular goal to revolutionize healthcare. We invest across the entire healthcare technology sector, from public and private biopharmaceutical companies, to early and late stage healthcare information technology companies, to commercial medical device companies.
With an exclusive focus on four sectors, we are highly selective in choosing our partners. When evaluating potential investments, we look for capable teams solving real problems in unique ways. Here are some of the criteria we consider:
NLVP invests in this sector from company creation through the initial public offering (IPO) and beyond. We work with experienced management teams that have developed novel product programs and platforms exemplified by several key characteristics – including large unmet medical needs, strong science, well differentiated technologies, and high-quality pre-clinical and clinical development programs. We believe that the best financial returns come from a focus on rigorous science and thorough data analysis, so our approach is largely science and data-driven. We currently invest in this sector through two vehicles:
NLV-III – Through our venture fund we seek to fund teams as early as the company creation stage through IPOs
NLV Growth-I – With our inaugural growth fund we invest in crossover rounds, IPOs, public financings as well as open market purchases